Login / Signup

A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease.

Miriam B VosRan JinJuna V KonomiRebecca CleetonJessica CruzSaul KarpenDellys Soler RodriguezJennifer K FredianiCourtney McCrackenJean Welsh
Published in: Pilot and feasibility studies (2018)
URL and trial identification number: https://clinicaltrials.gov/show/NCT01913470, NCT01913470.Date registered: August 1, 2013.
Keyphrases
  • phase iii
  • open label
  • study protocol
  • phase ii
  • clinical trial
  • double blind
  • placebo controlled
  • angiotensin ii
  • bioinformatics analysis
  • liver fibrosis
  • randomized controlled trial